Clinical Hospital of Medicine Faculty of Ribeirão Preto, University of São Paolo
Ribeirão Preto, São Paulo, 14048-800, Brazil
NCT Number: NCT01281215
The purpose of this study is to develop, implement and evaluate an economically viable and efficient interventions education model for rational drug use, adaptable to different pathological situations and should be implemented into Brazil Heath Care System.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ribeirão Preto, São Paulo, 14048-800, Brazil
Currently, the educational interventions regarding the use of medicines need to be expanded and more effective, and thus set themselves up in strategies for reorganization of dispensing drugs in health services and provide support to the population to obtain greater control over their health. The pharmacist, in turn, inserted in the multidisciplinary team has an important role in health education with the aim of improving knowledge about the disease and the various treatment options, reflecting positively on treatment adherence and clinical outcomes as a result and quality of life related to patient health. Thus, health education, to share knowledge, represents an important task and involves attentive listening to the community to identify their needs and then solve them. From this perspective, therefore, the educational means to educate health and an integral formation of individuals as social actors critics who understand and question the social relations, transforming subjects into citizens participating in the process of health education, helping to raise awareness , knowledge and understanding of living conditions and relationships with health, promoting quality of life.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The patients will receive pharmaceutical education to know more about asthma, the importance of treatment compliance, the medications used to control the pathology, corrected patients' inhalation techniques and the medication care.
Other names: Pharmaceutical Care
Time frame: 6 months after the first evaluation
To compare the patient´s knowledge of asthma before and after the education interventions with asthma knowledge questionnaire.
Time frame: 6 months after the first evaluation
To compare the patient´s pulmonary function before and after the education interventions with spirometry exam.
Time frame: 6 months after the first evaluation
To evaluate the sociodemographic data, clinical and lifestyle before and after the education interventions and its impact on the quality of life.
Time frame: 6 months after the first evaluation
To evaluate the technique for using inhalation devices among asthma patients before and after education interventions. Patients will be asked to demonstrate their inhaler technique.
Time frame: 6 months after the first evaluation
To evaluate the treatment compliance with Morisky&Green test and pharmacy database query before and after educations interventions.
Time frame: 6 months after the first evaluation
Economic analysis after the model implementation.
Time frame: 6 months after the first evaluation
To compare the Quality of Life before and after the education interventions
University of Sao Paulo
Other
Education Interventions Model for Rational Drug Use
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07394127
Asthma, Asthma Chronic
Gümüşhane, Trabzon, Ordu, Giresun, Rize, Artvin, Gümüşhane, Turkey (Türkiye)
View Trial DetailsNCT01678222
Allergic Inflammation, Asthma
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT03937804
Asthma, Bronchial Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial Details